Aprogen Biologics Inc. (KRX:003060)

Aprogen Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	110,641	130,793	190,684	200,481	360,706	524,120
Market Cap Growth	-32.12%	-31.41%	-4.89%	-44.42%	-31.18%	60.07%
Enterprise Value	326,676	176,792	383,113	209,570	302,520	379,267
Last Close Price	560.00	662.00	2203.94	3822.70	6877.82	9993.74
PE Ratio	-	-	-	15.86	44.52	46.58
PS Ratio	1.48	1.94	2.18	3.08	6.39	9.83
PB Ratio	0.35	0.35	0.52	0.39	0.60	0.88
P/TBV Ratio	0.46	0.35	0.53	0.48	0.71	1.04
P/FCF Ratio	-	-	-	8.20	-	73.70
P/OCF Ratio	-	-	-	7.79	-	64.80
EV/Sales Ratio	4.36	2.62	4.39	3.22	5.36	7.11
EV/EBITDA Ratio	-	-	-	-	-	445.50
EV/FCF Ratio	-6.06	-	-	8.57	-	53.33
Debt / Equity Ratio	0.61	0.41	0.49	0.26	0.00	0.01
Debt / EBITDA Ratio	-	-	-	-	-	3.49
Debt / FCF Ratio	-	-	-	5.51	-	0.42
Asset Turnover	0.12	0.11	0.14	0.10	0.09	0.11
Inventory Turnover	1.85	1.50	1.98	1.25	3.09	3.25
Quick Ratio	0.32	0.38	0.17	0.75	15.45	25.69
Current Ratio	0.86	0.78	0.54	1.49	37.41	38.79
Return on Equity (ROE)	-51.80%	-28.09%	-26.24%	2.46%	1.53%	4.00%
Return on Assets (ROA)	-10.83%	-6.20%	-6.94%	-0.40%	-0.40%	-0.14%
Return on Capital (ROIC)	-12.74%	-6.77%	-7.40%	-0.42%	-0.41%	-0.14%
Return on Capital Employed (ROCE)	-27.30%	-13.20%	-16.40%	-0.80%	-0.70%	-0.20%
Earnings Yield	-175.60%	-80.26%	-62.02%	6.30%	2.25%	2.15%
FCF Yield	-48.71%	-35.37%	-32.38%	12.19%	-1.95%	1.36%
Buyback Yield / Dilution	-113.01%	-99.40%	-56.07%	-1.42%	-25.52%	-94.17%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.